Cargando…
Corticosteroids and COVID-19: What Could Be the Best Bet in Treating Active Glomerular Diseases in Patients With Concomitant Early COVID-19?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by the National Kidney Foundation, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521867/ https://www.ncbi.nlm.nih.gov/pubmed/32991947 http://dx.doi.org/10.1053/j.ajkd.2020.09.006 |
| _version_ | 1783588059561852928 |
|---|---|
| author | Nayak, Saurabh Bharati, Joyita |
| author_facet | Nayak, Saurabh Bharati, Joyita |
| author_sort | Nayak, Saurabh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7521867 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | by the National Kidney Foundation, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75218672020-09-29 Corticosteroids and COVID-19: What Could Be the Best Bet in Treating Active Glomerular Diseases in Patients With Concomitant Early COVID-19? Nayak, Saurabh Bharati, Joyita Am J Kidney Dis Correspondence by the National Kidney Foundation, Inc. 2021-01 2020-09-28 /pmc/articles/PMC7521867/ /pubmed/32991947 http://dx.doi.org/10.1053/j.ajkd.2020.09.006 Text en © 2020 by the National Kidney Foundation, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Nayak, Saurabh Bharati, Joyita Corticosteroids and COVID-19: What Could Be the Best Bet in Treating Active Glomerular Diseases in Patients With Concomitant Early COVID-19? |
| title | Corticosteroids and COVID-19: What Could Be the Best Bet in Treating Active Glomerular Diseases in Patients With Concomitant Early COVID-19? |
| title_full | Corticosteroids and COVID-19: What Could Be the Best Bet in Treating Active Glomerular Diseases in Patients With Concomitant Early COVID-19? |
| title_fullStr | Corticosteroids and COVID-19: What Could Be the Best Bet in Treating Active Glomerular Diseases in Patients With Concomitant Early COVID-19? |
| title_full_unstemmed | Corticosteroids and COVID-19: What Could Be the Best Bet in Treating Active Glomerular Diseases in Patients With Concomitant Early COVID-19? |
| title_short | Corticosteroids and COVID-19: What Could Be the Best Bet in Treating Active Glomerular Diseases in Patients With Concomitant Early COVID-19? |
| title_sort | corticosteroids and covid-19: what could be the best bet in treating active glomerular diseases in patients with concomitant early covid-19? |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521867/ https://www.ncbi.nlm.nih.gov/pubmed/32991947 http://dx.doi.org/10.1053/j.ajkd.2020.09.006 |
| work_keys_str_mv | AT nayaksaurabh corticosteroidsandcovid19whatcouldbethebestbetintreatingactiveglomerulardiseasesinpatientswithconcomitantearlycovid19 AT bharatijoyita corticosteroidsandcovid19whatcouldbethebestbetintreatingactiveglomerulardiseasesinpatientswithconcomitantearlycovid19 |